NCT07655284
STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy
Not Yet Recruiting
PHASE3Ages 18+InterventionalTreatmentBrigham and Women's HospitalInvestigator-initiated
~190 participants
Updated 2026-06-22 on ClinicalTrials.gov
What's tested:ureteral stentsno ureteral stent
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Post-operative readmission rate
Measured over 30-days after surgery
Conditions
Where it's being run
2 sites across 2 statesMassachusetts1
São Paulo1
Study leadership
- Timothy N Clinton, MD · PRINCIPAL_INVESTIGATOR · Brigham and Women's Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adults (\> 18 years old)
Muscle invasive bladder cancer or non-muscle invasive bladder cancer with indication of Radical Cystectomy
No concomitant surgeries like nephrectomies, colectomies or removal of other organs affected by the tumor (Except standard lymph node dissections as well as in men the prostate and seminal vesicles and in women the uterus, fallopian tubes, ovaries and vagina, that are considered part of the oncological radical cystectomy.)
Patients who have the capacity to understand the study procedures and provide written informed consent
History of prior urinary diversion
Patients who decline to participate, lack understanding of the study's purpose, or are unable to provide informed consent
Cystectomy for other reasons than Bladder cancer
Previous radiation therapy in the pelvis for any reason
Extremely debilitated patients, malnourished individuals, or those undergoing palliative or hygienic cystectomy
What this trial measures
- Post-operative readmission rate30-days after surgery
percent of patients re-admitted